Featured Research

from universities, journals, and other organizations

HPV test detects more pre-cancerous cells than conventional smear test

Date:
April 28, 2010
Source:
BMJ-British Medical Journal
Summary:
Human papillomavirus screening detects more cervical severe pre-cancerous lesions than conventional cervical screening, a new study finds.

Human papillomavirus (HPV) screening detects more cervical severe pre-cancerous lesions than conventional cervical screening, finds a study published online in the British Medical Journal.

This is the first study to include the HPV test in an established cervical screening programme and the findings are important for cervical cancer prevention, says Dr Ahti Anttila at the Finnish Cancer Registry, who led the research.

HPV is a common sexually transmitted infection seen most often in young women and adolescents. There are more than 100 types of HPV -- some cause only genital warts, but others cause cancers including cervical cancer.

The study involved 58,282 women aged 30-60 years who were invited to participate in the routine cervical screening programme in Southern Finland between 2003 and 2005.

Women were randomly allocated to either an HPV test, with further screening if the test was positive, or to conventional cytology screening (the smear test or Pap test). Women were then tracked for a maximum of five years.

The results show that HPV screening was more sensitive than conventional cytology screening in detecting severe pre-cancerous lesions on the surface of the cervix (known as cervical intraepithelial neoplasia or CIN III+).

Although the overall number of cervical cancer cases detected was small, the authors conclude that "considering the high probability of progression of CIN III lesions in women aged 35 years or more, our results are important for prevention of cervical cancer."


Story Source:

The above story is based on materials provided by BMJ-British Medical Journal. Note: Materials may be edited for content and length.


Journal Reference:

  1. Ahti Anttila, Laura Kotaniemi-Talonen, Maarit Leinonen, Matti Hakama, Pekka Laurila, Jussi Tarkkanen, Nea Malila, and Pekka Nieminen. Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme. BMJ, 2010; 340 (apr27 1): c1804 DOI: 10.1136/bmj.c1804

Cite This Page:

BMJ-British Medical Journal. "HPV test detects more pre-cancerous cells than conventional smear test." ScienceDaily. ScienceDaily, 28 April 2010. <www.sciencedaily.com/releases/2010/04/100427190943.htm>.
BMJ-British Medical Journal. (2010, April 28). HPV test detects more pre-cancerous cells than conventional smear test. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2010/04/100427190943.htm
BMJ-British Medical Journal. "HPV test detects more pre-cancerous cells than conventional smear test." ScienceDaily. www.sciencedaily.com/releases/2010/04/100427190943.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins